1. Home
  2. ELSE vs PHGE Comparison

ELSE vs PHGE Comparison

Compare ELSE & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Electro-Sensors Inc.

ELSE

Electro-Sensors Inc.

HOLD

Current Price

$4.54

Market Cap

16.0M

Sector

Industrials

ML Signal

HOLD

Logo BiomX Inc. COmmon Stock

PHGE

BiomX Inc. COmmon Stock

HOLD

Current Price

$2.36

Market Cap

6.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELSE
PHGE
Founded
1968
2015
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.0M
6.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ELSE
PHGE
Price
$4.54
$2.36
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$26.00
AVG Volume (30 Days)
2.9K
124.8K
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.12
N/A
Revenue
$9,787,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$38.90
N/A
Revenue Growth
5.36
N/A
52 Week Low
$3.65
$2.28
52 Week High
$5.50
$22.06

Technical Indicators

Market Signals
Indicator
ELSE
PHGE
Relative Strength Index (RSI) 44.81 48.79
Support Level $4.48 $2.31
Resistance Level $4.70 $2.85
Average True Range (ATR) 0.06 0.59
MACD -0.00 -0.22
Stochastic Oscillator 34.78 35.00

Price Performance

Historical Comparison
ELSE
PHGE

About ELSE Electro-Sensors Inc.

Electro-Sensors Inc manufactures and sells industrial production monitoring and process control systems. It manufactures a complete line of monitoring and control systems for a wide range of industrial machine applications. The systems measure machine production and operation rates, as well as regulate the speed of related machines in production processes. Its products include motor drive control, position monitors, sensor targets, signal conditioners, speed sensors, speed switches, tachometers, temperature sensors, vibration monitors, etc.

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

Share on Social Networks: